Cargando…

Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis

BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuda, Eiichi, Anzai, Itsuki, Nomura, Takao, Toichi, Keisuke, Watanabe, Masahiko, Ohara, Shinji, Watanabe, Seiji, Yamanaka, Koji, Morisaki, Yuta, Misawa, Hidemi, Furukawa, Yoshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216565/
https://www.ncbi.nlm.nih.gov/pubmed/28057013
http://dx.doi.org/10.1186/s13024-016-0145-9
_version_ 1782491937390985216
author Tokuda, Eiichi
Anzai, Itsuki
Nomura, Takao
Toichi, Keisuke
Watanabe, Masahiko
Ohara, Shinji
Watanabe, Seiji
Yamanaka, Koji
Morisaki, Yuta
Misawa, Hidemi
Furukawa, Yoshiaki
author_facet Tokuda, Eiichi
Anzai, Itsuki
Nomura, Takao
Toichi, Keisuke
Watanabe, Masahiko
Ohara, Shinji
Watanabe, Seiji
Yamanaka, Koji
Morisaki, Yuta
Misawa, Hidemi
Furukawa, Yoshiaki
author_sort Tokuda, Eiichi
collection PubMed
description BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has been proposed as one of the misfolding pathways occurring in mutant SOD1; however, the pathological relevance of such oligomerization in the SOD1-ALS cases still remains obscure. METHODS: We prepared antibodies exclusively recognizing the SOD1 oligomers cross-linked via disulfide bonds in vitro. By using those antibodies, immunohistochemical examination and ELISA were mainly performed on the tissue samples of transgenic mice expressing mutant SOD1 proteins and also of human SOD1-ALS cases. RESULTS: We showed the recognition specificity of our antibodies exclusively toward the disulfide-crosslinked SOD1 oligomers by ELISA using various forms of purified SOD1 proteins in conformationally distinct states in vitro. Furthermore, the epitope of those antibodies was buried and inaccessible in the natively folded structure of SOD1. The antibodies were then found to specifically detect the pathological SOD1 species in the spinal motor neurons of the SOD1-ALS patients as well as the transgenic model mice. CONCLUSIONS: Our findings here suggest that the SOD1 oligomerization through the disulfide-crosslinking associates with exposure of the SOD1 structural interior and is a pathological process occurring in the SOD1-ALS cases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0145-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5216565
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52165652017-01-09 Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis Tokuda, Eiichi Anzai, Itsuki Nomura, Takao Toichi, Keisuke Watanabe, Masahiko Ohara, Shinji Watanabe, Seiji Yamanaka, Koji Morisaki, Yuta Misawa, Hidemi Furukawa, Yoshiaki Mol Neurodegener Research Article BACKGROUND: Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has been proposed as one of the misfolding pathways occurring in mutant SOD1; however, the pathological relevance of such oligomerization in the SOD1-ALS cases still remains obscure. METHODS: We prepared antibodies exclusively recognizing the SOD1 oligomers cross-linked via disulfide bonds in vitro. By using those antibodies, immunohistochemical examination and ELISA were mainly performed on the tissue samples of transgenic mice expressing mutant SOD1 proteins and also of human SOD1-ALS cases. RESULTS: We showed the recognition specificity of our antibodies exclusively toward the disulfide-crosslinked SOD1 oligomers by ELISA using various forms of purified SOD1 proteins in conformationally distinct states in vitro. Furthermore, the epitope of those antibodies was buried and inaccessible in the natively folded structure of SOD1. The antibodies were then found to specifically detect the pathological SOD1 species in the spinal motor neurons of the SOD1-ALS patients as well as the transgenic model mice. CONCLUSIONS: Our findings here suggest that the SOD1 oligomerization through the disulfide-crosslinking associates with exposure of the SOD1 structural interior and is a pathological process occurring in the SOD1-ALS cases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13024-016-0145-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-05 /pmc/articles/PMC5216565/ /pubmed/28057013 http://dx.doi.org/10.1186/s13024-016-0145-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tokuda, Eiichi
Anzai, Itsuki
Nomura, Takao
Toichi, Keisuke
Watanabe, Masahiko
Ohara, Shinji
Watanabe, Seiji
Yamanaka, Koji
Morisaki, Yuta
Misawa, Hidemi
Furukawa, Yoshiaki
Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title_full Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title_fullStr Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title_full_unstemmed Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title_short Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
title_sort immunochemical characterization on pathological oligomers of mutant cu/zn-superoxide dismutase in amyotrophic lateral sclerosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216565/
https://www.ncbi.nlm.nih.gov/pubmed/28057013
http://dx.doi.org/10.1186/s13024-016-0145-9
work_keys_str_mv AT tokudaeiichi immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT anzaiitsuki immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT nomuratakao immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT toichikeisuke immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT watanabemasahiko immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT oharashinji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT watanabeseiji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT yamanakakoji immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT morisakiyuta immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT misawahidemi immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis
AT furukawayoshiaki immunochemicalcharacterizationonpathologicaloligomersofmutantcuznsuperoxidedismutaseinamyotrophiclateralsclerosis